ANGN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 birž. 2023 @ 23:00):

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases...

Stats
Dzisiejszy wolumen	224 803
Średni wolumen	9 772.00
Kapitalizacja rynkowa	30.11M
EPS	$0 ( 2024-03-15 )
Następna data zysków	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0989
ATR14	$0.0950 (9.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Nissenson Allen	Buy	4 100	Stock Option (right to buy)
2023-12-28	Chudnovsky Yekaterina	Buy	4 100	Stock Option (right to buy)
2023-12-28	Wilson Karen J	Buy	4 100	Stock Option (right to buy)
2023-12-28	Adams Julian	Buy	4 100	Stock Option (right to buy)
2023-12-28	Venkatesan Jay	Buy	4 100	Stock Option (right to buy)

INSIDER POWER
56.58
Last 97 transactions
Buy: 4 979 407 \| Sell: 2 616 033

Wolumen Korelacja

Długi: 0.38 (neutral)

Krótki: 0.32 (neutral)

Signal:(71.808) Neutral

Angion Biomedica Corp. Korelacja

10 Najbardziej pozytywne korelacje
MYSZ	0.924
SMFL	0.92
ALXO	0.915
IRBT	0.914
SSPK	0.913
TRIT	0.908
SPCX	0.905
VNDA	0.903
NCBS	0.903
MTP	0.902

10 Najbardziej negatywne korelacje
CFFE	-0.929
ARIZ	-0.924
LRMR	-0.922
ROCL	-0.922
OTEC	-0.919
FICV	-0.916
OVLY	-0.915
AIB	-0.914
FATP	-0.914
EMLD	-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Angion Biomedica Corp. Korelacja - Waluta/Towar

-0.37
( neutral )

0.16
( neutral )

0.00
( neutral )

-0.42
( neutral )

-0.45
( neutral )

-0.46
( neutral )

Angion Biomedica Corp. Finanse

Annual	2022
Przychody:	$2.30M
Zysk brutto:	$2.30M (100.00 %)
EPS:	$-1.850

FY	2022
Przychody:	$2.30M
Zysk brutto:	$2.30M (100.00 %)
EPS:	$-1.850

FY	2021
Przychody:	$28.31M
Zysk brutto:	$27.88M (98.47 %)
EPS:	$-1.930

FY	2020
Przychody:	$2.88M
Zysk brutto:	$1.69M (58.68 %)
EPS:	$-2.78

Financial Reports:

No articles found.

Angion Biomedica Corp.

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

Aktualne aktualizacje dla Angion Biomedica Corp. [ANGN]

Upcoming Earnings Alert